Speech by Federal Chancellor Dr. Angela Merkel at the opening of the Materials Research Center of Merck KGaA on September 23, 2010, in Darmstadt:

Germany Angela Merkel · Former Chancellor of Germany

25 September 2010 · Opening of the Materials Research Center of Merck KGaA · Materials Research Center of Merck KGaA, Darmstadt, Germany

Context
Merkel addressed guests at the opening of Merck KGaA's new Materials Research Center in Darmstadt on September 23, 2010, celebrating innovation and German industry.
Main themes
Innovation and research investment, materials science and high-tech industry, Merck KGaA corporate history, Germany as a technology location, education and STEM promotion, family business values, sustainability and social responsibility, globalization and competitiveness, public-private partnership, demographic challenges, long-term corporate management
Duration
~16 min
55th percentile
Words
1,936
55th percentile
Sentences
101
63rd percentile
Readability
48
58th percentile
Grade
11.0
33rd percentile
Syntax
2.92
37th percentile
Vocabulary
2.04
15th percentile

Translated from German

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 36%36%
  • Technological 21%21%
  • Social 19%19%
  • Ceremonial 17%17%
  • Institutional 4%4%
  • Geopolitical 2%2%
  • Environmental 2%2%
  • Not in focus 0%

101 sentences in 27 paragraphs

Dear Mr. Kley,

dear Mr. Wilhelm,

Mr. Prime Minister, dear Volker Bouffier,

dear Mr. Mayor,

Mr. District Administrator,

dear colleagues from the federal, state, and municipal parliaments,

Mr. Parliamentary State Secretary,

dear employees, some of whom are also joining us via live stream – how could it be otherwise in a high-tech company? –, ladies and gentlemen,

"Chemistry shapes the future" – this was the title of a comprehensive campaign by the German Chemical Industry Association. It seems that the Merck Group has been a godparent to this motto. Here, in the new Materials Research Center, the future is being created, as I believe. That is why I am pleased to be in this traditional and high-tech company and in this beautiful federal state, Mr. Prime Minister, and of course in this beautiful city, to mention the Mayor once again. I also warmly welcome the members of the Merck family.

The investments here at Merck's headquarters follow a long tradition of the family business. The chairman of the works council just mentioned it: It is a family business that lives its values and demonstrates them in daily actions. The roots, which date back to 1668, have already been mentioned. What began with a pharmacy is today regarded as the oldest pharmaceutical and chemical company with a global reputation. A vivid example of long-term corporate management is the development of liquid crystals, which began over 100 years ago – one can hardly believe it. These are responsible today, among other things, for the image quality of countless screens – whether on computers, mobile phones, and much more. This shows that it is worthwhile – and this is also Germany's strength – to continue developments with great continuity. That is why it is so important – and I was very pleased with the words of the chairman of the works council – that innovation is regarded as something necessary to secure the prosperity of tomorrow. We cannot afford any setbacks on this path; we must continue steadily, especially in a globalized world, because others around us are not resting.

I believe that Merck is a company that stands pars pro toto for Germany's innovative strength. It is a top company among the best. So it was only a matter of time before you received an award. I believe the "IMD - Global Family Business Award" last year was an accolade that encompassed everything that is lived here. First and foremost, we must mention the topic of personnel policy, the motivation of the people who work here; indeed, all those who contribute to a chain of developments. Last year, Merck was ranked sixth by a trade magazine among the world's best employers in the biotechnology and pharmaceutical industry. I believe this reflects what you are achieving here on site.

Your good reputation is also enhanced by the fact that you have always maintained a connection to society alongside your core work. For example, there is the donation program to combat tropical diseases, as well as cultural promotion. We are looking forward to hearing the "Philharmonie Merck" later. My heartfelt request: No matter how strong the pressure of globalization may be, do not forget this societal connection. I believe that in the long run, it will pay off. This is also – today we are celebrating the "1st Hessian Day of Sustainability" – a piece of sustainability in the truest sense of the word.

What Merck advances is ultimately good for our entire country. To remain a leading technology location in the future, we need bright young people who are enthusiastic about technology and the natural sciences. Here, you are setting a good example – whether through school partnerships or through long-standing participation in the nationwide competition "Youth Research." Just yesterday, I hosted the best of this competition at the Federal Chancellery. The demographic structure of our society and the fact that the number of young people is unfortunately not increasing, but rather decreasing, make the question of education and research a central issue for Germany as a location. Therefore, early engagement by companies to develop joy and initiative regarding research in young people is, of course, extraordinarily valuable and complementary to what we do on the government side.

Now, the chairman of the works council has already made a small assessment of the various activities of the federal government. While we may not agree on everything, I believe we can say: It is a step in the right direction that we are now spending twelve billion euros more on education and research in this legislative period. This shows that we are focusing on the future viability of Germany.

For we know: Companies like Merck and others, including many small and medium-sized enterprises – Mr. Wilhelm pointed out various start-ups – certainly need state incentives time and again to advance in research. We can never replace entrepreneurial activities, but we see everywhere in the world that the state and companies work closely together when it comes to the direction of research and technology. I believe that with the high-tech strategy developed by the Federal Minister of Research, we have created a very, very good framework to advance research and in which we also form scientific alliances with companies.

This Materials Research Center is also dealing with topics that play a role in the high-tech strategy. Organic electronics is something that opens up unprecedented new possibilities. The so-called organic light-emitting diodes – there are hardly any German terms left today – that is, OLED displays, are very present. We will see what this means later on. The expectations of what this organic electronics can still achieve are very high. I also believe that there can still be many intelligent applications here. We truly have something here that distinguishes Germany as a world market leader and, of course, must be consistently further developed.

Overall, we can be very proud of our strengths in physics, chemistry, materials science, and engineering. However – for which I am also grateful to the company – we must continually advocate for these areas, because in many discussions, the focus on the question of what risk something entails sometimes takes precedence over the question of what opportunities lie within it. I do not want to downplay the risks of research and development. They must be considered. But one must not overlook the opportunities. This is a company that has always seen these opportunities in partnership between management and employees.

The business partners of the innovation alliances for organic light-emitting diodes and organic photovoltaics have committed to invest 800 million euros by 2015. This is five times the public funding, so it is a very good example of state and private research cooperation. I believe that on this basis, we can also further develop the field of organic electronics, which is of great importance.

I could mention many, many examples from the high-tech strategy. I will only mention the topic of electromobility again, because Merck is working on the battery of tomorrow. I suspect that one needs quite a bit of endurance in this exciting race. The expectations that society sometimes has regarding certain research areas can be very, very high. Others are not even brought into focus. The question of how we advance in the development of new electrolyte materials to improve the performance and lifespan of lithium-ion batteries will decide much in the future. Therefore, I wish Merck good luck in being at the forefront of this development.

Merck is indeed an interesting company: The fields of chemistry and pharmaceuticals are represented and well developed. In this respect, I believe it is time, even though we are currently more active on the materials side, to reiterate that the pharmaceutical location Germany has always been one of our showcases and should continue to be so in the future. I believe that for the acceptance of research and development, the products of the pharmaceutical industry are of utmost importance, because in a society that has more and more elderly people, thinking about health and how to cure diseases is one of the central questions.

Since we just passed a new health reform yesterday, which has generated the usual critical accompanying tones, I would like to say here once again in all seriousness: A country that wants to maintain an excellent healthcare system, a country that has a population whose average life expectancy is increasing, must be willing to spend more money for good medical care. If this willingness is not there, we will slide towards a two-tier healthcare system. I do not want that. Therefore, my heartfelt request to all those who work in the pharmaceutical sector is to make it very clear that good healthcare is truly worth something to us. We are envied in the world for our healthcare system. We want to continue to be a leader in the pharmaceutical sector. But this also requires that we are willing to tell people that a fair price must be paid for it.

Merck is one of the companies – I hope Mr. Kley is not sad that I place Merck among other successful companies in Germany – that has contributed to our successful navigation through a very, very difficult economic time. This has been possible because we rely on innovations and because we have a lived social partnership in Germany. The fact that Mr. Kley and Mr. Wilhelm appeared together here today shows the willingness to do so.

During this economic crisis, we have seen in many places how employees have shown a great deal of understanding for the difficult situation. We have seen how politics and business have worked together to maintain what is our treasure, namely the expertise of engineers, skilled workers, and masters, through certain means, such as short-time work, and to build a bridge for them, saying: Better economic times will come again. I think we should continue on this path. We should look to the future and see the opportunities. Then, in my firm conviction, Germany has every opportunity to remain a leading country in the world.

But there are also dangers. The dangers lie in the fact that we are not making things easy for ourselves with many projects today. I do not want to talk about controversial projects here today, as there are also encouraging examples in Hesse – for instance, when I think of the expansion of Frankfurt Airport – where a conscious decision has been made for the future. But we cannot become a country that, for example, implements an energy transition with renewable energies if no one wants to build a high-voltage line anymore. We cannot have a modern energy supply if we first ask about the risks at every turn.

That is why it is so important that Merck today sets a sign for the future, that Merck sets a sign for research and innovation, and that 50 million euros have been invested for the future. I believe this is good for the products that will emerge, but it is also good for the people. For those who have work, who can engage in society, are part of it. This contributes to the cohesion of society.

Hesse is a good home for Merck. Stay true to your roots amidst all globalization, amidst all revenue outside your home country. This not only pleases the German Chancellor, it not only pleases the Prime Minister and the Mayor, but above all, it pleases the people who have work here and who contribute with their performance to the wonderful achievements being made here.

Congratulations on the inauguration of this center.